Endocyte, Inc. (ECYT) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ECYT Hot Sheet
Join SI Premium – FREE
Endocyte, Inc. (NASDAQ: ECYT) reported Q2 EPS of ($0.35), $0.07 worse than the analyst estimate of ($0.28).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Five Below (FIVE) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY27 Guidance
- Sprinklr (CXM) Tops Q1 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
